Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.
about
Role of HLA Adaptation in HIV EvolutionIdentification of a cluster of HIV-1 controllers infected with low replicating virusesHIV replication capacity is an independent predictor of disease progression in persons with untreated chronic HIV infection.HIV-1 Transmission, Replication Fitness and Disease Progression.Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infectionHIV RNA level in early infection is predicted by viral load in the transmission source.Impaired replication capacity of acute/early viruses in persons who become HIV controllers.High viral fitness during acute HIV-1 infection.Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.Human immunodeficiency virus type 1 protease inhibitor drug-resistant mutants give discordant results when compared in single-cycle and multiple-cycle fitness assays.Select resistance-associated mutations in blood are associated with lower CSF viral loads and better neuropsychological performance.Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children.Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.Interplay between single resistance-associated mutations in the HIV-1 protease and viral infectivity, protease activity, and inhibitor sensitivityReplication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patientsChanges in simian immunodeficiency virus reverse transcriptase alleles that appear during infection of macaques enhance infectivity and replication in CD4+ T cells.Differential infection patterns of CD4+ T cells and lymphoid tissue viral burden distinguish progressive and nonprogressive lentiviral infections.Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in JapanPersistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.Clinical significance of human immunodeficiency virus type 1 replication fitness.Rationale for the design of an oncology trial using a generic targeted therapy multi‑drug regimen for NSCLC patients without treatment options (Review)Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progressionReplication Capacity of Viruses from Acute Infection Drives HIV-1 Disease Progression.Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replication.Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.Evolution of human immunodeficiency virus type 1 protease genotypes and phenotypes in vivo under selective pressure of the protease inhibitor ritonavir.Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility.Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans.Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection
P2860
Q26772713-9D88BF6B-E516-45A8-BB6A-D190BCBF6D63Q28534737-A0F7895B-EAB7-4E4E-A057-282F934EBE42Q33721788-AEE4358A-6C56-4956-8B2F-BE770C39FDB5Q33758570-719FA771-9F71-4163-8D1B-5B05D885FE26Q33877481-02700669-C12E-4115-985A-FD0A3B780164Q33921382-12E3A86E-EA59-48AA-B1AA-85D320A9DB23Q33963989-58DE280F-0DB8-4DCE-BF9D-2AC5802112E0Q34115280-9D2298D4-337E-4F1B-A48B-8D1682A4F622Q34120857-0D8C818C-377C-4DF1-AD74-208CC2D1AFE5Q34262204-EF39CF2E-2DD9-46A0-86F4-B99697F87D0EQ34489422-86A5572D-646B-4853-A830-8A9045D577DDQ34615228-A71FE740-8CAF-4CFC-9E3F-C60CD448062FQ34803017-6734EE08-1DC9-4ED7-8226-4850FF5BA3FCQ35076519-147F42A6-8000-4571-93FF-2A12C862BF29Q35689381-6D0F5955-9A82-4FCF-A313-A1B8C7183024Q36351352-233DE5CA-E8F2-4962-8797-4F46F6E9D896Q36367759-9B6A8868-6FBD-47D8-8814-A1EC16B9BB46Q36376773-F09917BB-6A9D-4DD4-956C-B29A441BB18DQ36410144-F468DE34-AEA0-4995-8C90-EDCD944EA004Q36559805-392EE16F-A6A1-4C0A-915A-BB7407007A58Q36673315-6FCD80E1-A70E-49A3-AFAE-6E03103830BFQ36969857-747EB09B-5460-4B97-A837-6A27C8B7F653Q37260992-70CF5238-EE44-48C8-A539-E1B0B0ABC3F0Q37743275-63D03511-4064-4042-A770-F65049E5843BQ38699481-70426655-01F2-4987-B2BD-1D76AE61AB3BQ38706845-ED435925-387A-4D83-9CE7-DC72E081B5EFQ39534825-C67751A3-0BCB-43E9-95EF-6F3153784117Q40349815-52ACDBE7-A2EC-4E70-BE7F-683530AC6411Q42125534-A4D76FEC-7F58-4EAD-A552-FC5BDCEEBC2AQ42737965-BBA9D362-B991-4251-893D-55A569B94526Q42931192-DE76630D-F08B-416E-8849-110514444860Q43077557-0FDFA5D8-0DD2-45B4-8335-AE61C749C709Q43221224-2428C00A-30E6-412C-BA2B-F6C0175E468BQ57206384-969BDABF-923C-407B-975E-1DC05C4383B0
P2860
Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Relationship between in vitro ...... rate and virus load in plasma.
@en
type
label
Relationship between in vitro ...... rate and virus load in plasma.
@en
prefLabel
Relationship between in vitro ...... rate and virus load in plasma.
@en
P2093
P2860
P1433
P1476
Relationship between in vitro ...... rate and virus load in plasma.
@en
P2093
Elizabeth Connick
Kristina Schneider
Terri Wrin
P2860
P304
12105-12112
P356
10.1128/JVI.77.22.12105-12112.2003
P407
P577
2003-11-01T00:00:00Z